瑞普生物:子公司取得消毒產品生產企業衞生許可證
格隆匯2月11日丨瑞普生物(300119.SZ)公佈,公司全資子公司瑞普天津近日取得由天津市衞生健康委員會頒發的消毒產品生產企業衞生許可證。生產項目:消毒劑;生產類別:粉劑消毒劑(含氯消毒劑);有效期限:新型冠狀病毒感染的肺炎疫情防控應急響應期內有效。
瑞普天津生產的“衞清寧”(過硫酸氫鉀複合物粉)屬於複合型含氯消毒劑,加入水中後可以持續產生次氯酸、新生態氧,通過氯化、氧化、酸化三重機制殺滅病原微生物,包括某些冠狀病毒、多數細菌、真菌等,被美國、英國等國家疫控部門核准用於重大疫情防控,也屬於國家衞生健康委發佈的《部分消毒劑在新型冠狀病毒感染的肺炎疫情防控期間緊急上市通知》(國衞辦監督函(2020)99號)中要求緊急上市的含氯消毒劑。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.